FemaSeed
Intratubal Insemination for Infertility
Key Facts
About Femasys
Femasys Inc. is a woman-founded, publicly-traded biomedical company on a mission to modernize the severely underserved field of women's health. The company has built a robust portfolio of in-office, non-surgical products based on a proprietary delivery platform that requires no capital equipment, aiming to improve accessibility and reduce costs. Key achievements include the commercial launch of its FemVue® diagnostic device and the advancement of its lead therapeutic candidates, FemaSeed® for infertility and FemBloc® for permanent contraception, through late-stage clinical trials. Its strategy leverages deep clinical familiarity, a strong IP portfolio of ~200 patents, and in-house manufacturing to bring transformative care directly to physicians' offices.
View full company profile